TEL AVIV, Israel, May 17, 2024 Chemomab Therapeutics Ltd. , a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today.
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - Chemomab Therapeutics (NASDAQ:CMMB) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need,
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.